Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucosamine-6-phosphate deaminase activity	GNPDA1 GNPDA2	5.76e-05	2	152	2	GO:0004342
GeneOntologyMolecularFunction	isocitrate dehydrogenase (NADP+) activity	IDH1 IDH2	5.76e-05	2	152	2	GO:0004450
GeneOntologyCellularComponent	cell cortex	ACTN4 FRYL ACTN1 ACTN3 DST DLC1 HMCN1 MACF1 FGFR2 PLS1 DYNC1H1	9.36e-05	371	153	11	GO:0005938
GeneOntologyCellularComponent	actin filament bundle	ACTN4 ACTN1 DST DLC1 AMOT PLS1	2.34e-04	118	153	6	GO:0032432
GeneOntologyCellularComponent	pseudopodium	ACTN4 ACTN1 ACTN3	2.89e-04	18	153	3	GO:0031143
Domain	ACTININ_2	ACTN4 ACTN1 ACTN3 DST MACF1 PLS1	2.56e-08	23	154	6	PS00020
Domain	ACTININ_1	ACTN4 ACTN1 ACTN3 DST MACF1 PLS1	2.56e-08	23	154	6	PS00019
Domain	Actinin_actin-bd_CS	ACTN4 ACTN1 ACTN3 DST MACF1 PLS1	2.56e-08	23	154	6	IPR001589
Domain	CH	CFAP47 ACTN4 ACTN1 ACTN3 DST ASPM MACF1 PLS1	1.09e-07	70	154	8	PF00307
Domain	-	CFAP47 ACTN4 ACTN1 ACTN3 DST ASPM MACF1 PLS1	1.22e-07	71	154	8	1.10.418.10
Domain	CH	CFAP47 ACTN4 ACTN1 ACTN3 DST ASPM MACF1 PLS1	1.52e-07	73	154	8	PS50021
Domain	CH-domain	CFAP47 ACTN4 ACTN1 ACTN3 DST ASPM MACF1 PLS1	1.88e-07	75	154	8	IPR001715
Domain	ARM-type_fold	DOCK1 USP34 MYBBP1A NBEAL1 IFT172 FRYL AP3B1 RYR3 ATP6V1H XPO5 PIK3C2B ASPM LRBA STAG2	8.60e-07	339	154	14	IPR016024
Domain	CH	ACTN4 ACTN1 ACTN3 DST ASPM MACF1 PLS1	1.05e-06	65	154	7	SM00033
Domain	Spectrin	ACTN4 ACTN1 ACTN3 DST MACF1	1.07e-06	23	154	5	PF00435
Domain	Spectrin_repeat	ACTN4 ACTN1 ACTN3 DST MACF1	3.61e-06	29	154	5	IPR002017
Domain	SPEC	ACTN4 ACTN1 ACTN3 DST MACF1	6.01e-06	32	154	5	SM00150
Domain	Spectrin/alpha-actinin	ACTN4 ACTN1 ACTN3 DST MACF1	6.01e-06	32	154	5	IPR018159
Domain	EFhand_Ca_insen	ACTN4 ACTN1 ACTN3	1.08e-05	6	154	3	PF08726
Domain	EF-hand_Ca_insen	ACTN4 ACTN1 ACTN3	1.08e-05	6	154	3	IPR014837
Domain	-	WDR64 COPA NBEAL1 IFT172 APAF1 SPAG9 PLXNB2 DDB2 LRBA PHIP PLXNA2 BRWD1	2.11e-05	333	154	12	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	WDR64 COPA NBEAL1 IFT172 APAF1 SPAG9 PLXNB2 DDB2 LRBA PHIP PLXNA2 BRWD1	2.24e-05	335	154	12	IPR015943
Domain	Glucosamine6P_isomerase_CS	GNPDA1 GNPDA2	6.75e-05	2	154	2	IPR018321
Domain	Glucosamine6P_isomerase	GNPDA1 GNPDA2	6.75e-05	2	154	2	IPR004547
Domain	Isocitrate_DH_NADP	IDH1 IDH2	6.75e-05	2	154	2	IPR004790
Domain	GLC_GALNAC_ISOMERASE	GNPDA1 GNPDA2	6.75e-05	2	154	2	PS01161
Domain	PP2Ac	PPP2CA PPP2CB PPP4C	1.48e-04	13	154	3	SM00156
Domain	Ser/Thr-sp_prot-phosphatase	PPP2CA PPP2CB PPP4C	1.48e-04	13	154	3	IPR006186
Domain	SER_THR_PHOSPHATASE	PPP2CA PPP2CB PPP4C	1.48e-04	13	154	3	PS00125
Domain	WD40_repeat_dom	WDR64 COPA NBEAL1 IFT172 APAF1 SPAG9 DDB2 LRBA PHIP BRWD1	1.82e-04	297	154	10	IPR017986
Domain	EF-hand_1	ACTN4 ACTN1 ACTN3 RYR3 DST MACF1 PLS1	2.69e-04	152	154	7	PF00036
Domain	WD40	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	3.04e-04	259	154	9	PF00400
Domain	WD40	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	3.91e-04	268	154	9	SM00320
Domain	Neural_cell_adh	NCAM2 HMCN1	4.01e-04	4	154	2	IPR009138
Domain	Glc/Gal-6P_isomerase	GNPDA1 GNPDA2	4.01e-04	4	154	2	IPR006148
Domain	Glucosamine_iso	GNPDA1 GNPDA2	4.01e-04	4	154	2	PF01182
Domain	WD40_repeat	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	4.35e-04	272	154	9	IPR001680
Domain	WD_REPEATS_1	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	5.09e-04	278	154	9	PS00678
Domain	WD_REPEATS_2	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	5.23e-04	279	154	9	PS50082
Domain	WD_REPEATS_REGION	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	5.23e-04	279	154	9	PS50294
Domain	EF-hand-dom_pair	ACTN4 ACTN1 ACTN3 RYR3 CAPN13 DST SCN9A MACF1 PLS1	6.40e-04	287	154	9	IPR011992
Domain	Isocitrate/isopropylmalate_DH	IDH1 IDH2	6.65e-04	5	154	2	IPR001804
Domain	Iso_dh	IDH1 IDH2	6.65e-04	5	154	2	PF00180
Domain	IsoCit/isopropylmalate_DH_CS	IDH1 IDH2	6.65e-04	5	154	2	IPR019818
Domain	Iso_dh	IDH1 IDH2	6.65e-04	5	154	2	SM01329
Domain	IDH_IMDH	IDH1 IDH2	6.65e-04	5	154	2	PS00470
Domain	DUF4704	NBEAL1 LRBA	6.65e-04	5	154	2	IPR031570
Domain	DUF4704	NBEAL1 LRBA	6.65e-04	5	154	2	PF15787
Domain	IsoPropMal-DH-like_dom	IDH1 IDH2	6.65e-04	5	154	2	IPR024084
Domain	-	IDH1 IDH2	6.65e-04	5	154	2	3.40.718.10
Domain	EF_HAND_2	ACTN4 ACTN1 ACTN3 RYR3 CAPN13 DST MACF1 PLS1	6.73e-04	231	154	8	PS50222
Domain	Rho_GTPase_activation_prot	OCRL PLXNB2 DLC1 DEPDC1B PLXNA2	8.07e-04	88	154	5	IPR008936
Domain	-	DST MACF1	9.91e-04	6	154	2	3.90.1290.10
Domain	PH_BEACH	NBEAL1 LRBA	9.91e-04	6	154	2	PF14844
Domain	GAR	DST MACF1	9.91e-04	6	154	2	PS51460
Domain	GAS2	DST MACF1	9.91e-04	6	154	2	PF02187
Domain	-	DST MACF1	9.91e-04	6	154	2	3.30.920.20
Domain	GAS_dom	DST MACF1	9.91e-04	6	154	2	IPR003108
Domain	GAS2	DST MACF1	9.91e-04	6	154	2	SM00243
Domain	Plectin	DST MACF1	1.38e-03	7	154	2	PF00681
Domain	Plectin_repeat	DST MACF1	1.38e-03	7	154	2	IPR001101
Domain	PLEC	DST MACF1	1.38e-03	7	154	2	SM00250
Domain	-	ACTN4 ACTN1 ACTN3 RYR3 CAPN13 DST MACF1 PLS1	1.48e-03	261	154	8	1.10.238.10
Domain	Metallophos	PPP2CA PPP2CB PPP4C	1.55e-03	28	154	3	PF00149
Domain	Calcineurin-like_PHP_ApaH	PPP2CA PPP2CB PPP4C	1.55e-03	28	154	3	IPR004843
Domain	Carboxylesterase_B_AS	CEL CES4A	1.83e-03	8	154	2	IPR019826
Domain	PH-BEACH_dom	NBEAL1 LRBA	1.83e-03	8	154	2	IPR023362
Domain	-	NBEAL1 LRBA	1.83e-03	8	154	2	2.30.29.40
Domain	PH_BEACH	NBEAL1 LRBA	1.83e-03	8	154	2	PS51783
Domain	CARBOXYLESTERASE_B_1	CEL CES4A	1.83e-03	8	154	2	PS00122
Domain	Metallo-depent_PP-like	PPP2CA PPP2CB PPP4C	1.90e-03	30	154	3	IPR029052
Domain	-	PPP2CA PPP2CB PPP4C	1.90e-03	30	154	3	3.60.21.10
Domain	EFh	ACTN4 ACTN1 ACTN3 DST MACF1 PLS1	2.00e-03	158	154	6	SM00054
Domain	Plexin_repeat	ATRN PLXNB2 PLXNA2	2.29e-03	32	154	3	IPR002165
Domain	PSI	ATRN PLXNB2 PLXNA2	2.29e-03	32	154	3	PF01437
Domain	Plexin_cytopl	PLXNB2 PLXNA2	2.34e-03	9	154	2	PF08337
Domain	BEACH	NBEAL1 LRBA	2.34e-03	9	154	2	PS50197
Domain	Beach	NBEAL1 LRBA	2.34e-03	9	154	2	PF02138
Domain	-	NBEAL1 LRBA	2.34e-03	9	154	2	1.10.1540.10
Domain	Beach	NBEAL1 LRBA	2.34e-03	9	154	2	SM01026
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNB2 PLXNA2	2.34e-03	9	154	2	IPR013548
Domain	BEACH_dom	NBEAL1 LRBA	2.34e-03	9	154	2	IPR000409
Domain	Plexin	PLXNB2 PLXNA2	2.34e-03	9	154	2	IPR031148
Domain	TPR_REGION	IFT172 ZC3H7A AIPL1 ZC3H7B TTC5 CABIN1	2.49e-03	165	154	6	PS50293
Domain	TPR	IFT172 ZC3H7A AIPL1 ZC3H7B TTC5 CABIN1	2.49e-03	165	154	6	PS50005
Domain	EF_hand_dom	ACTN4 ACTN1 ACTN3 RYR3 DST MACF1 PLS1	3.17e-03	232	154	7	IPR002048
Domain	IQ	IQCN IQCA1 SCN9A ASPM	4.52e-03	81	154	4	SM00015
Domain	Carboxylesterase_B_CS	CEL CES4A	4.96e-03	13	154	2	IPR019819
Domain	START	STARD6 DLC1	4.96e-03	13	154	2	SM00234
Domain	PSI	ATRN PLXNB2 PLXNA2	5.68e-03	44	154	3	IPR016201
Domain	CARBOXYLESTERASE_B_2	CEL CES4A	5.76e-03	14	154	2	PS00941
Domain	COesterase	CEL CES4A	5.76e-03	14	154	2	PF00135
Domain	CarbesteraseB	CEL CES4A	5.76e-03	14	154	2	IPR002018
Domain	Ldl_recept_a	TMPRSS4 LRP5 RXFP1	6.05e-03	45	154	3	PF00057
Domain	PSI	ATRN PLXNB2 PLXNA2	6.44e-03	46	154	3	SM00423
Domain	-	TMPRSS4 LRP5 RXFP1	6.44e-03	46	154	3	4.10.400.10
Domain	IQ_motif_EF-hand-BS	IQCN IQCA1 SCN9A ASPM	6.56e-03	90	154	4	IPR000048
Domain	START_lipid-bd_dom	STARD6 DLC1	6.61e-03	15	154	2	IPR002913
Domain	START	STARD6 DLC1	6.61e-03	15	154	2	PF01852
Domain	START	STARD6 DLC1	6.61e-03	15	154	2	PS50848
Domain	ARM-like	FRYL AP3B1 ATP6V1H XPO5 ASPM LRBA STAG2	7.17e-03	270	154	7	IPR011989
Domain	LDLRA_1	TMPRSS4 LRP5 RXFP1	7.25e-03	48	154	3	PS01209
Domain	IQ	IQCN IQCA1 SCN9A ASPM	7.36e-03	93	154	4	PS50096
Domain	LDrepeatLR_classA_rpt	TMPRSS4 LRP5 RXFP1	7.68e-03	49	154	3	IPR002172
Domain	LDLa	TMPRSS4 LRP5 RXFP1	7.68e-03	49	154	3	SM00192
Pathway	REACTOME_GLUCOSE_METABOLISM	GPI GNPDA1 PFKM NUP35 PPP2CA PPP2CB GNPDA2	6.93e-06	85	118	7	M1870
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK USP34 ANGPT1 APAF1 SPAG9 DST XPO5 CADPS AMOT CHD5 MACF1 OGA	4.96e-10	225	156	12	12168954
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	USP34 GNPDA1 COPA ACTN4 RO60 FRYL SPAG9 ACTN1 IDH1 PFKM AP3B1 DDB2 PPP2CA PPP2CB RNF123 ATP6V1H PPP4C XPO5 INTS13 GNPDA2 MACF1 AP1M1 LRBA OGA PLS1 DYNC1H1	1.77e-09	1455	156	26	22863883
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TNIK MYBBP1A GNPDA1 COPA APAF1 GATM AP3B1 DST XPO5 CADPS NT5DC2 SLC25A1 MACF1 STAG2 PHIP	8.41e-09	498	156	15	36634849
Pubmed	α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse.	ACTN4 ACTN1 ACTN3	8.85e-08	3	156	3	21784188
Pubmed	Alpha-actinin and vinculin in human neutrophils: reorganization during adhesion and relation to the actin network.	ACTN4 ACTN1 ACTN3	3.53e-07	4	156	3	1629252
Pubmed	Disruption of alpha-actinin-integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis.	ACTN4 ACTN1 ACTN3	3.53e-07	4	156	3	16807302
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPI MYBBP1A COPA COX4I1 LRRC49 MTMR1 NCAM2 ACTN4 ACTN1 ACTN3 IDH2 PFKM AP3B1 PPP2CB ATP6V1H DST ATP8A1 CADPS AMOT SLC17A7 MACF1 DYNC1H1	4.77e-07	1431	156	22	37142655
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	TNIK LRRC49 MTMR1 OCRL FAM171B PLXNB2 PTPN14 DST PIK3C2B MACF1 LRBA DEPDC1B	4.96e-07	421	156	12	36976175
Pubmed	Genetic characterization of important mouse strains used in cancer research.	GPI HLA-G IDH1 IDH2	5.12e-07	15	156	4	75870
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	GPI MYBBP1A ANKS6 IFT172 EI24 ACTN4 SPAG9 ACTN1 OCRL IDH2 AP3B1 PPP2CB GTF2H1 PTPN14 GPBP1L1 XPO5 AMOT AIPL1 POMK DEPDC1B DYNC1H1	5.21e-07	1321	156	21	27173435
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYBBP1A ZNF789 COPA ACTN4 ACTN1 ACTN3 PFKM NUP35 ZC3H7A PPP2CA PPP2CB DST DNAJC10 SLC25A1 CHD5 SCN9A ASPM MACF1 DLEC1 PLS1 STAG2 PLXNA2	5.42e-07	1442	156	22	35575683
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	TNIK MYBBP1A COPA APAF1 IDH2 MORC2 AP3B1 NUP35 PPP2CB PPP4C SLC25A1 AP1M1 LRBA ZC3H7B DYNC1H1	7.32e-07	704	156	15	29955894
Pubmed	Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner.	ACTN4 ACTN1 ACTN3	8.79e-07	5	156	3	15841212
Pubmed	The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin.	ACTN4 ACTN1 ACTN3	8.79e-07	5	156	3	12837758
Pubmed	Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction.	ACTN4 ACTN1 ACTN3	8.79e-07	5	156	3	19943616
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	GPI MYBBP1A COPA MTMR1 MPDZ ACTN4 SPAG9 ACTN1 IDH1 IDH2 AP3B1 PPP2CA DST PELO XPO5 AMOT MACF1 OGA DYNC1H1	1.07e-06	1149	156	19	35446349
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	MYBBP1A COPA IFT172 MTMR1 MPDZ IDH2 MORC2 PPP2CA DNAJC10 CADPS SCN9A PHIP	1.75e-06	475	156	12	31040226
Pubmed	Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.	ACTN4 ACTN1 ACTN3	1.75e-06	6	156	3	18425115
Pubmed	The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway.	ACTN4 ACTN1 ACTN3	1.75e-06	6	156	3	22693585
Pubmed	Alpha 4 associates with protein phosphatases 2A, 4, and 6.	PPP2CA PPP2CB PPP4C	1.75e-06	6	156	3	9647778
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 ABCC3 ANKS6 FRYL PIGG PTCH1 PLXNB2 PPP2CB DST PIK3C2B CHD5 LRP5 FGFR2 LRBA ZC3H7B TTC5 CABIN1 DYNC1H1	2.58e-06	1105	156	18	35748872
Pubmed	LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.	GPI ACTN1 ACTN3 IDH1 DST HMCN1 DYNC1H1	3.82e-06	142	156	7	30809309
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DOCK1 MYBBP1A COPA MTMR1 MPDZ OCRL AP3B1 ATP6V1H DST XPO5 MACF1 LRBA DEPDC1B DYNC1H1	4.12e-06	708	156	14	39231216
Pubmed	FGF signalling through Fgfr2 isoform IIIb regulates adrenal cortex development.	CYP11A1 DLK1 FGFR2	4.88e-06	8	156	3	23376610
Pubmed	CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function.	ACTN4 ACTN1 ACTN3	4.88e-06	8	156	3	20215401
Pubmed	Mice deficient in alpha-actinin-4 have severe glomerular disease.	ACTN4 ACTN1 ACTN3	4.88e-06	8	156	3	12782671
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATRN USP34 COPA IFT172 GATM NCAM2 ACTN4 ACTN1 RYR3 RNF123 DST CADPS SCG2 MACF1 LRBA CABIN1 DYNC1H1 BRWD1 SOS2	5.40e-06	1285	156	19	35914814
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	DOCK1 ANKS6 NBEAL1 OCRL AP3B1 DST DNAJC10 AP1M1 LRBA	6.12e-06	285	156	9	34369648
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	MYBBP1A COPA IFT172 ACTN4 SPAG9 ACTN1 AP3B1 DNAJC10 XPO5 AP1M1 LRBA STAG2 DYNC1H1	6.70e-06	638	156	13	33239621
Pubmed	Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.	ACTN1 ACTN3 PPP2CA	7.29e-06	9	156	3	11114196
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 MYBBP1A COPA ACTN4 FRYL SPAG9 ACTN1 DST XPO5 MACF1 STAG2 PHIP DYNC1H1	8.58e-06	653	156	13	22586326
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	USP34 IFT172 MTMR1 MPDZ ACTN4 SPAG9 PFKM AP3B1 PPP2CA ATP6V1H PTPN14 DNAJC10 XPO5 NT5DC2 TMEM131L PLS1	8.68e-06	974	156	16	28675297
Pubmed	Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.	ACTN4 ACTN1 ACTN3	1.04e-05	10	156	3	20368620
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	GPI COPA ACTN4 ACTN1 ATP6V1H MACF1 OGA DYNC1H1	1.18e-05	235	156	8	28378594
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 RCOR2 YEATS2 GTF2H1 PTPN14 PELO DNAJC10 CADPS TYW5 INTS13 NT5DC2 CHD5 ASPM MACF1 PHIP PDZRN3 BRWD1	1.19e-05	1116	156	17	31753913
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	GPI COX4I1 ACTN4 ACTN1 PFKM PPP2CA PPP2CB ATP6V1H SLC17A7 DYNC1H1	1.53e-05	403	156	10	30562941
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK UBR2 IFT172 SNX13 YEATS2 XPO5 CADPS MACF1 DYNC1H1 PLXNA2	1.66e-05	407	156	10	12693553
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	GPI MYBBP1A COPA ACTN4 IQCN ACTN1 IDH1 IDH2 AP3B1 DST SLC25A1 MACF1 LRBA DYNC1H1	1.79e-05	807	156	14	30575818
Pubmed	Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase.	ACTN4 ACTN1 ACTN3	1.89e-05	12	156	3	15465019
Pubmed	Metabolism unhinged: IDH mutations in cancer.	IDH1 IDH2	2.00e-05	2	156	2	21383741
Pubmed	IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?	IDH1 IDH2	2.00e-05	2	156	2	30176240
Pubmed	Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.	IDH1 IDH2	2.00e-05	2	156	2	34078652
Pubmed	IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.	IDH1 IDH2	2.00e-05	2	156	2	23894344
Pubmed	High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.	IDH1 IDH2	2.00e-05	2	156	2	21480859
Pubmed	Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population.	IDH1 IDH2	2.00e-05	2	156	2	29874711
Pubmed	Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.	PPP2CA PPP2CB	2.00e-05	2	156	2	2555176
Pubmed	Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.	IDH1 IDH2	2.00e-05	2	156	2	23391413
Pubmed	Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.	IDH1 IDH2	2.00e-05	2	156	2	29126125
Pubmed	Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.	IDH1 IDH2	2.00e-05	2	156	2	20142433
Pubmed	IDH1 and IDH2 mutations in gliomas.	IDH1 IDH2	2.00e-05	2	156	2	23532369
Pubmed	[IDH1/2 mutations in gliomas].	IDH1 IDH2	2.00e-05	2	156	2	22147457
Pubmed	Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study.	GNPDA1 GNPDA2	2.00e-05	2	156	2	12965206
Pubmed	The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.	IDH1 IDH2	2.00e-05	2	156	2	23015095
Pubmed	Absence of IDH mutation in colorectal cancers with microsatellite instability.	IDH1 IDH2	2.00e-05	2	156	2	26987944
Pubmed	Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions.	IDH1 IDH2	2.00e-05	2	156	2	23111198
Pubmed	Insular primary glioblastomas with IDH mutations: Clinical and biological specificities.	IDH1 IDH2	2.00e-05	2	156	2	28116838
Pubmed	Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.	IDH1 IDH2	2.00e-05	2	156	2	20538800
Pubmed	IDH mutations in older patients with diffuse astrocytic gliomas.	IDH1 IDH2	2.00e-05	2	156	2	33137656
Pubmed	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.	IDH1 IDH2	2.00e-05	2	156	2	25783747
Pubmed	Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia.	IDH1 IDH2	2.00e-05	2	156	2	23039322
Pubmed	Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.	IDH1 IDH2	2.00e-05	2	156	2	31609487
Pubmed	Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.	IDH1 IDH2	2.00e-05	2	156	2	32027343
Pubmed	Cloning and functional characterization of GNPI2, a novel human homolog of glucosamine-6-phosphate isomerase/oscillin.	GNPDA1 GNPDA2	2.00e-05	2	156	2	12616532
Pubmed	Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.	IDH1 IDH2	2.00e-05	2	156	2	23918605
Pubmed	IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management.	IDH1 IDH2	2.00e-05	2	156	2	31876581
Pubmed	IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.	IDH1 IDH2	2.00e-05	2	156	2	21997850
Pubmed	Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.	IDH1 IDH2	2.00e-05	2	156	2	22136423
Pubmed	Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.	IDH1 IDH2	2.00e-05	2	156	2	32382048
Pubmed	Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience.	IDH1 IDH2	2.00e-05	2	156	2	34162262
Pubmed	Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia.	IDH1 IDH2	2.00e-05	2	156	2	35351982
Pubmed	Murine calmodulin binding protein 1 (Calmbp1): tissue-specific expression during development and in adult tissues.	APAF1 ASPM	2.00e-05	2	156	2	12351193
Pubmed	Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.	IDH1 IDH2	2.00e-05	2	156	2	28297679
Pubmed	Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.	IDH1 IDH2	2.00e-05	2	156	2	22002076
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	2.00e-05	2	156	2	11002341
Pubmed	Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.	IDH1 IDH2	2.00e-05	2	156	2	22520341
Pubmed	[IDH1- and IDH2-mutations in brain glial tumors - the new antioncogenic mechanism].	IDH1 IDH2	2.00e-05	2	156	2	29863707
Pubmed	Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q).	IDH1 IDH2	2.00e-05	2	156	2	31685963
Pubmed	IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.	IDH1 IDH2	2.00e-05	2	156	2	21598255
Pubmed	An analysis of splicing, actin-binding properties, heterodimerization and molecular interactions of the non-muscle α-actinins.	ACTN4 ACTN1	2.00e-05	2	156	2	23557398
Pubmed	Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.	IDH1 IDH2	2.00e-05	2	156	2	31068457
Pubmed	A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.	IDH1 IDH2	2.00e-05	2	156	2	22922872
Pubmed	IDH Mutations in AML Patients; A higher Association with Intermediate Risk Cytogenetics.	IDH1 IDH2	2.00e-05	2	156	2	32212799
Pubmed	IDH mutations occur frequently in Chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas.	IDH1 IDH2	2.00e-05	2	156	2	21874255
Pubmed	IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression.	IDH1 IDH2	2.00e-05	2	156	2	26228814
Pubmed	Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.	IDH1 IDH2	2.00e-05	2	156	2	22427879
Pubmed	Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.	IDH1 IDH2	2.00e-05	2	156	2	21996744
Pubmed	IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker.	IDH1 IDH2	2.00e-05	2	156	2	23451940
Pubmed	Regulation of spindle formation by active mitogen-activated protein kinase and protein phosphatase 2A during mouse oocyte meiosis.	PPP2CA PPP2CB	2.00e-05	2	156	2	11751260
Pubmed	Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.	IDH1 IDH2	2.00e-05	2	156	2	38842680
Pubmed	A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.	IDH1 IDH2	2.00e-05	2	156	2	20962861
Pubmed	Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.	IDH1 IDH2	2.00e-05	2	156	2	28552826
Pubmed	The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.	IDH1 IDH2	2.00e-05	2	156	2	26046462
Pubmed	Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors.	IDH1 IDH2	2.00e-05	2	156	2	23232569
Pubmed	Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.	IDH1 IDH2	2.00e-05	2	156	2	23641016
Pubmed	Distinct IDH1/IDH2 mutation profiles in purely insular versus paralimbic WHO Grade II gliomas.	IDH1 IDH2	2.00e-05	2	156	2	23330999
Pubmed	IDH1/2 Mutations in Sinonasal Undifferentiated Carcinomas : Previously Undescribed IDH2 R172K and R140x Variants.	IDH1 IDH2	2.00e-05	2	156	2	35486703
Pubmed	Metabolism of glioma and IDH1/IDH2 mutations.	IDH1 IDH2	2.00e-05	2	156	2	21885076
Pubmed	IDH1/2 Mutations in Cancer Stem Cells and Their Implications for Differentiation Therapy.	IDH1 IDH2	2.00e-05	2	156	2	34967233
Pubmed	Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status.	IDH1 IDH2	2.00e-05	2	156	2	22790483
Pubmed	IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution.	IDH1 IDH2	2.00e-05	2	156	2	32333643
Cytoband	2q32.1	FAM171B NUP35 DNAJC10	1.46e-04	30	156	3	2q32.1
GeneFamily	Actinins	ACTN4 ACTN1 ACTN3	7.80e-07	4	106	3	1112
GeneFamily	WD repeat domain containing	WDR64 COPA NBEAL1 IFT172 APAF1 DDB2 LRBA PHIP BRWD1	2.37e-05	262	106	9	362
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP2CA PPP2CB PPP4C	5.37e-05	13	106	3	693
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	9.32e-04	8	106	2	939
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 LRBA	1.19e-03	9	106	2	1230
GeneFamily	Plexins	PLXNB2 PLXNA2	1.19e-03	9	106	2	683
GeneFamily	ATP binding cassette subfamily C	ABCC3 ABCC9	2.55e-03	13	106	2	807
GeneFamily	StAR related lipid transfer domain containing	STARD6 DLC1	3.40e-03	15	106	2	759
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN	DOCK1 IFT172 ACTN3 AP3B1 GPBP1L1 PPP4C DNAJC10 LRP5 LRBA STAG2	3.16e-07	200	154	10	M3969
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 ATRN USP34 UBR2 FRYL SPAG9 ZMIZ1 AP3B1 SNX13 PPP2CA ATP6V1H DST DLC1 TMEM131L MACF1 STAG2 PHIP SOS2	3.07e-06	856	154	18	M4500
Coexpression	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	UBR2 OLFML2B FRYL RYR3 TMEM260 DST MYLIP TMEM131L FGFR2 PDZRN3 SOS2	5.75e-06	340	154	11	M2012
Coexpression	SAGIV_CD24_TARGETS_UP	USP34 FRYL ASPM PHIP	7.72e-06	22	154	4	M4144
Coexpression	JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP	ACTN4 SPAG9 ACTN1 CHKB PLXNB2 PPP2CB DLC1 SCN9A MACF1 FBXO32 DYNC1H1	1.71e-05	382	154	11	M38972
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	ACTN1 PTCH1 PLXNB2 GTF2H1 SCN9A TMEM131L MACF1 DLEC1	2.43e-05	199	154	8	M5240
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	DOCK1 ANGPT1 LRRC49 GATM NDN DLK1 OCRL IDH2 RCOR2 HMCN1 CSF3R NT5DC2 ASPM	7.73e-06	410	151	13	GSM791122_500
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	DOCK1 ANGPT1 GATM MPDZ DLK1 OCRL IDH2 RCOR2 HMCN1 CSF3R NT5DC2 ASPM DEPDC1B	1.08e-05	423	151	13	GSM791126_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	DOCK1 APAF1 NCAM2 ST8SIA1 ZMIZ1 FAM171B SNX13 DLC1 ASPM OGA PHIP	2.51e-05	330	151	11	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2	DOCK1 ADGRG3 ANGPT1 PGLYRP1 OLFML2B CYP11A1 GATM IDH1 CSF3R NT5DC2 ASPM DEPDC1B	2.60e-05	394	151	12	GSM777030_500
CoexpressionAtlas	Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3	DOCK1 ADGRG3 IL31RA ANGPT1 GATM IDH1 IDH2 PLXNB2 BPHL CSF3R NT5DC2 ASPM	3.17e-05	402	151	12	GSM791105_500
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	DOCK1 ADGRG3 ANGPT1 PGLYRP1 LRRC49 GATM NDN OCRL RCOR2 DST CSF3R NT5DC2	5.06e-05	422	151	12	GSM399442_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200	CYP11A1 GATM PTCH1 TMC3 DLC1 HMCN1 CADPS	5.96e-05	138	151	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200
CoexpressionAtlas	Stem Cells, SC.LT34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34-, Bone marrow, avg-3	DOCK1 ADGRG3 ANGPT1 LRRC49 GATM RO60 NDN OCRL PFKM DST CSF3R	6.26e-05	365	151	11	GSM791102_500
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	APAF1 RO60 NDN ACTN3 ST8SIA1 FAM171B PTCH1 ATP8A1 HMCN1 CADPS MYLIP ZC3H7B PDZRN3 PLXNA2 BRWD1 SOS2	1.67e-04	791	151	16	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2	DOCK1 ADGRG3 ANGPT1 LRRC49 GATM OCRL IDH2 PFKM CSF3R NT5DC2 ASPM	1.78e-04	411	151	11	GSM791112_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	TNIK OLFML2B GATM ABCC9 DLK1 ST8SIA1 IDH1 TST PLXNB2 TMC3 YEATS2 DLC1 HMCN1 AMOT FGFR2 PLXNA2	1.82e-04	797	151	16	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2	ADGRG3 ANGPT1 PGLYRP1 GATM CSF3R	1.85e-04	74	151	5	GSM777030_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	DOCK1 ANGPT1 APAF1 ABCC9 RO60 ST8SIA1 FAM171B RYR3 SNX13 DST DLC1 HMCN1 ASPM OGA PHIP PLXNA2	2.07e-04	806	151	16	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	B cells, MLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-3	ADGRG3 ANGPT1 GATM NDN DLK1 IDH1 IDH2 RCOR2 CSF3R NT5DC2 DEPDC1B	2.38e-04	425	151	11	GSM791131_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	DOCK1 APAF1 NCAM2 ST8SIA1 ZMIZ1 FAM171B RYR3 SNX13 DLC1 ATP8A1 CADPS ASPM RXFP1 OGA DEPDC1B PHIP	2.44e-04	818	151	16	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANGPT1 NCAM2 GRIK4 ST8SIA1 DST DLC1 HMCN1 MACF1 PDZRN3	2.67e-08	193	155	9	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL31RA ACTN1 ZMIZ1 FAM171B DST HMCN1 MACF1 PDZRN3 PLXNA2	3.05e-08	196	155	9	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL31RA ACTN1 ZMIZ1 FAM171B DST HMCN1 MACF1 PDZRN3 PLXNA2	3.05e-08	196	155	9	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B OLFML2B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	1.38e-07	168	155	8	7abaddbcc55e44653d54aa15464266aa6bd5c9d2
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ABCC9 GRIK4 TMC3 RYR3 DLC1 ASPM RXFP1	1.81e-07	174	155	8	43c0e758fa8683708475aec846929ac70d41d7f5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B OLFML2B ABCC9 RYR3 DLC1 SLC17A7 RXFP1 KCNH5	1.81e-07	174	155	8	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 TMC3 RYR3 DLC1 RXFP1 KCNH5	2.24e-07	179	155	8	f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 RYR3 DLC1 SLC17A7 RXFP1 KCNH5	2.34e-07	180	155	8	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 TMC3 RYR3 DLC1 RXFP1 KCNH5	2.66e-07	183	155	8	65f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ABCC3 HLA-G PIGG PTCH1 BPHL TYW5 FBXO32 LRBA	3.01e-07	186	155	8	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ABCC3 HLA-G PIGG PTCH1 BPHL TYW5 FBXO32 LRBA	3.01e-07	186	155	8	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRMT9B RYR3 QRFPR MYLIP TMEM150C RXFP1 PLS1	3.18e-07	127	155	7	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	B3GALNT1 ANGPT1 MPDZ NDN RYR3 DST DLC1 SCN9A	3.39e-07	189	155	8	2157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ANGPT1 NCAM2 GRIK4 DST HMCN1 MACF1 PDZRN3 PLXNA2	3.83e-07	192	155	8	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 NCAM2 ST8SIA1 DST DLC1 HMCN1 MACF1 PDZRN3	3.98e-07	193	155	8	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATRN USP34 NBEAL1 RO60 FRYL POMK STAG2 DYNC1H1	3.98e-07	193	155	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANGPT1 NCAM2 GRIK4 DST DLC1 HMCN1 MACF1 PDZRN3	3.98e-07	193	155	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 NCAM2 ST8SIA1 DST DLC1 HMCN1 MACF1 PDZRN3	4.14e-07	194	155	8	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNIK ANGPT1 NCAM2 GRIK4 PTCH1 DST HMCN1 PDZRN3	4.14e-07	194	155	8	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK1 GRIK4 DST DLC1 HMCN1 PIK3C2B MACF1 RXFP1	4.14e-07	194	155	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 TNIK TRMT9B ABCC3 TMPRSS4 XKR6 PTPN14 DST	4.30e-07	195	155	8	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 TNIK TRMT9B ABCC3 TMPRSS4 XKR6 PTPN14 DST	4.30e-07	195	155	8	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EVC2 ARHGEF28 APAF1 GATM QRFPR PTPN14 PDZRN3	1.27e-06	156	155	7	2cd007b423c2395c5ce331902e7f27c805755eb3
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ARHGEF28 TMPRSS4 ACTN3 CADPS AMOT TMEM150C	1.64e-06	162	155	7	3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1
ToppCell	facs-Thymus-Epithelium-3m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ARHGEF28 TMPRSS4 ACTN3 CADPS AMOT TMEM150C	1.64e-06	162	155	7	0a7138266054ea5954649c8b61ef93905d56b068
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ARHGEF28 TMPRSS4 ACTN3 CADPS AMOT TMEM150C	1.64e-06	162	155	7	25323785dd33337bcefd05958a4a1a208a9ceb04
ToppCell	moderate-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TNIK ST8SIA1 DLC1 PIK3C2B CADPS SCG2 TMEM150C	1.93e-06	166	155	7	c3835b424c63bf11a4e2c47635dc3787fc4a637a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B OLFML2B ABCC9 RYR3 DLC1 RXFP1 KCNH5	2.26e-06	170	155	7	417b77c12a7982b1ce4b4bc57f30335d261220f5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	OLFML2B ABCC9 GRIK4 TMC3 RYR3 DLC1 RXFP1	2.54e-06	173	155	7	95c723b09254ae7131fe5ba0841472502e83269b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	2.74e-06	175	155	7	90e29945aa861082c94bb4f331161adc3a6ef899
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 TMC3 RYR3 DLC1 RXFP1	2.84e-06	176	155	7	72a2a01618ce836bc843395d5095e9090759b4a6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	2.84e-06	176	155	7	e4b21fd6a5e0c5950f27c3e1868318e48330ae5e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 RYR3 DLC1 SLC17A7 RXFP1 KCNH5	2.95e-06	177	155	7	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	3.06e-06	178	155	7	431e7557b8e8764e16e9e48368ce6bfa3c61561a
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMPRSS4 CAPN13 PTPN14 IQCA1 CTNNA3 FGFR2 PLXNA2	3.06e-06	178	155	7	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	3.42e-06	181	155	7	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 ST8SIA1 ATP8A1 TMEM131L MACF1 LRBA OGA	3.42e-06	181	155	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCC3 ARHGEF28 OLFML2B NCAM2 SLC17A7 RXFP1 PLXNA2	3.55e-06	182	155	7	205d9ad1ea4b7adee8054496cdde46c9c401a19a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCC9 GRIK4 RYR3 DLC1 ASPM RXFP1 PLXNA2	3.55e-06	182	155	7	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCC9 GRIK4 RYR3 DLC1 ASPM RXFP1 PLXNA2	3.55e-06	182	155	7	05c167158815bf25d509df59ab386e1990712765
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGEF28 NCAM2 SCG2 ASPM SLC17A7 RXFP1 PLXNA2	3.81e-06	184	155	7	ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 RO60 PTPN14 DLC1 PIK3C2B MYLIP ZC3H7B	3.95e-06	185	155	7	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 NCAM2 GRIK4 ST8SIA1 DST CABIN1 PLXNA2	3.95e-06	185	155	7	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGEF28 NCAM2 SCG2 ASPM SLC17A7 RXFP1 PLXNA2	4.09e-06	186	155	7	77b09af860183606a1775eba921e2071e4a7dd4e
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	ANGPT1 NCAM2 GRIK4 DST HMCN1 MACF1 PDZRN3	4.24e-06	187	155	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	TNIK ABCC9 SPAG9 IQCN DLC1 ATP8A1 CSF3R	4.24e-06	187	155	7	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	B3GALNT1 OLFML2B ABCC9 NDN GRIK4 ACTN3 PDZRN3	4.24e-06	187	155	7	8bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	B3GALNT1 OLFML2B ABCC9 NDN GRIK4 ACTN3 PDZRN3	4.24e-06	187	155	7	3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	TRMT9B ARHGEF28 NBEAL1 ACTN1 RYR3 MACF1 PDZRN3	4.39e-06	188	155	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CFAP47 ARHGEF28 ATP8A1 CTNNA3 SCN9A FGFR2 PLS1	4.55e-06	189	155	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNIK ANGPT1 NCAM2 GRIK4 DST HMCN1 PDZRN3	4.55e-06	189	155	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	moderate-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	IL31RA CEL HLA-G DST SCG2 SCN9A PDZRN3	4.55e-06	189	155	7	6011b747e27d61d222380a7bffdd921a68e9b657
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 OLFML2B ABCC9 NDN GRIK4 FGFR2 PDZRN3	4.71e-06	190	155	7	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC9 ACTN1 DLC1 CADPS CTNNA3 TMEM131L RXFP1	4.71e-06	190	155	7	5681c211baeed4af82a2bbc13420f6a7b487581c
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 OLFML2B ABCC9 NDN GRIK4 FGFR2 PDZRN3	4.71e-06	190	155	7	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 ABCC9 ST8SIA1 PTCH1 DST DLC1 PDZRN3	4.87e-06	191	155	7	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANGPT1 NCAM2 GRIK4 DST HMCN1 MACF1 PDZRN3	4.87e-06	191	155	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANGPT1 NCAM2 GRIK4 DST HMCN1 MACF1 PDZRN3	5.04e-06	192	155	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN1 IDH1 ZMIZ1 HMCN1 NT5DC2 MACF1 PDZRN3	5.22e-06	193	155	7	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 TRMT9B IQCA1 CES4A VWA3B DLEC1 PLXNA2	5.22e-06	193	155	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 TRMT9B ABCC3 TMPRSS4 ACTN1 XKR6 PTPN14	5.22e-06	193	155	7	263d185af6ed80e639f864e4966268e0862c61dc
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 COPA PLXNB2 DST ATP8A1 CADPS SCG2	5.22e-06	193	155	7	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ANGPT1 NCAM2 GRIK4 DST HMCN1 MACF1 PLXNA2	5.22e-06	193	155	7	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNIK ANGPT1 NCAM2 GRIK4 DST HMCN1 PDZRN3	5.40e-06	194	155	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	facs-Skin-Anagen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN1 IDH1 ZMIZ1 HMCN1 NT5DC2 MACF1 PDZRN3	5.40e-06	194	155	7	5d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG3 ARHGEF28 PGLYRP1 ACTN1 RYR3 HMCN1 CSF3R	5.58e-06	195	155	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG3 ARHGEF28 PGLYRP1 ACTN1 RYR3 HMCN1 CSF3R	5.58e-06	195	155	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2B DST CSF3R SCG2 MYLIP MACF1 LRBA	5.58e-06	195	155	7	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	ANGPT1 NCAM2 GRIK4 ST8SIA1 DST HMCN1 PDZRN3	5.58e-06	195	155	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	ANGPT1 NCAM2 GRIK4 DST DLC1 HMCN1 PDZRN3	5.58e-06	195	155	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCC3 ACTN1 DST CADPS SCG2 SLC17A7 FBXO32	5.77e-06	196	155	7	19993604ee64ba85e3f53a784fcf1c934e862f61
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OLFML2B ABCC9 ACTN1 DLC1 HMCN1 RXFP1 PDZRN3	5.77e-06	196	155	7	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OLFML2B ABCC9 ACTN1 DLC1 HMCN1 RXFP1 PDZRN3	5.77e-06	196	155	7	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCC3 ACTN1 PLXNB2 RYR3 DST DLC1 SCG2	5.77e-06	196	155	7	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TNIK ANGPT1 GRIK4 DST DLC1 MACF1 PDZRN3	5.77e-06	196	155	7	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANGPT1 NCAM2 GRIK4 DST DLC1 HMCN1 PDZRN3	5.77e-06	196	155	7	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TNIK ABCC3 ANGPT1 GRIK4 DST DLC1 MACF1	5.97e-06	197	155	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TNIK ANGPT1 NCAM2 GRIK4 HMCN1 MACF1 PDZRN3	5.97e-06	197	155	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TNIK ANGPT1 GRIK4 DST DLC1 MACF1 PDZRN3	6.17e-06	198	155	7	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 MPDZ DST DLC1 HMCN1 MACF1 BRWD1	6.59e-06	200	155	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	6.59e-06	200	155	7	e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNIK CFAP47 FAM171B RYR3 IQCA1 MACF1 FGFR2	6.59e-06	200	155	7	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	6.59e-06	200	155	7	1ce9599cc9d8158e8842ca56f35fa7809c234849
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	OLFML2B ABCC9 ACTN1 PTCH1 CTNNA3 FBXO32 PDZRN3	6.59e-06	200	155	7	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 UBR2 FRYL SPAG9 MACF1 PHIP DYNC1H1	6.59e-06	200	155	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	6.59e-06	200	155	7	7b845aabfbdfe893acc9334a5707833761bed60b
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANGPT1 NCAM2 GRIK4 ST8SIA1 DLC1 HMCN1 PDZRN3	6.59e-06	200	155	7	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Neuronal-Excitatory-eD(FEZF2)-ABO\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TRMT9B ABCC9 GRIK4 RYR3 DLC1 RXFP1 KCNH5	6.59e-06	200	155	7	0638273fc0910f47fe7a0b6d9a8639b0e9976d13
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	OLFML2B ABCC9 ACTN1 PTCH1 PELO CTNNA3 FBXO32	6.59e-06	200	155	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRMT9B RYR3 QRFPR MYLIP TMEM150C PLS1	8.24e-06	136	155	6	1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRMT9B RYR3 QRFPR MYLIP TMEM150C PLS1	9.73e-06	140	155	6	7cc891d676555609add6fc7880735d948a2ad801
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRMT9B OLFML2B QRFPR MYLIP TMEM150C PLS1	1.01e-05	141	155	6	40ef6d792e11fe10963d64eb0b606b90556c1a70
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TRMT9B ST8SIA1 RYR3 QRFPR TMEM150C PLS1	1.14e-05	144	155	6	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	(02)_Cycling_Basal_(regeneration)-(2)_48hpi\|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint	PGLYRP1 TMPRSS4 IDH1 BPHL FBXO32 OGA	1.34e-05	148	155	6	a061a745c09254e063411b7d835d5597a0007e29
ToppCell	Children_(3_yrs)-Immune-mast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK PGLYRP1 ST8SIA1 RYR3 PIK3C2B CADPS	1.50e-05	151	155	6	bbf735c6433c3fc2feedb24ed6f48c51d545fb60
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARHGEF28 ANGPT1 GRIK4 HMCN1 SCN9A RXFP1	1.61e-05	153	155	6	9c6fce56300ba5053efda59a438d63a808c497c0
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	NCAM2 GRIK4 CADPS CTNNA3 RXFP1 KCNH5	2.01e-05	159	155	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TRMT9B ANGPT1 GRIK4 DST LRP5 MACF1	2.08e-05	160	155	6	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TRMT9B ANGPT1 GRIK4 DST LRP5 MACF1	2.08e-05	160	155	6	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 PGLYRP1 PTCH1 PLXNB2 TMEM260 LRP5	2.15e-05	161	155	6	3f3a2148c8d65e6a06f8d8116a3aa58dda17d618
Drug	prostaglandin A1	GPI ACTN4 ACTN1 ACTN3 IDH2	3.25e-06	34	155	5	ctd:C100573
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; HL60; HG-U133A	MTMR1 ZMIZ1 PTCH1 TST PLXNB2 DDB2 YEATS2 NT5DC2 MYLIP	3.76e-06	178	155	9	1736_DN
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; PC3; HT_HG-U133A	ABCC3 MTMR1 TMPRSS4 ABCC9 NDN PPP2CB DLC1 FGFR2 ZC3H7B	8.57e-06	197	155	9	5092_UP
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; PC3; HT_HG-U133A	TNIK USP34 ARHGEF28 SPAG9 OCRL MACF1 ZC3H7B OGA BRWD1	8.93e-06	198	155	9	5813_DN
Disease	focal segmental glomerulosclerosis 1 (implicated_via_orthology)	ACTN4 ACTN1 ACTN3	1.36e-06	5	153	3	DOID:0111128 (implicated_via_orthology)
Disease	Seizures	CYP11A1 MPDZ IDH2 ZMIZ1 PPP2CA KAT8 SLC17A7 MACF1	1.93e-05	218	153	8	C0036572
Disease	hepatocellular clear cell carcinoma (is_implicated_in)	IDH1 IDH2	2.67e-05	2	153	2	DOID:5016 (is_implicated_in)
Disease	Chondroma	IDH1 IDH2	2.67e-05	2	153	2	C0936248
Disease	Enchondroma	IDH1 IDH2	2.67e-05	2	153	2	C1704356
Disease	cortical thickness	TNIK TRMT9B ANGPT1 NBEAL1 LRRC49 ABCC9 ACTN4 XKR6 PTCH1 DLC1 XPO5 CADPS NT5DC2 MACF1 DLEC1 PLXNA2 SOS2	6.96e-05	1113	153	17	EFO_0004840
Disease	Cardiovascular Abnormalities	ANKS6 ZMIZ1 KAT8	7.29e-05	16	153	3	C0243050
Disease	Maffucci Syndrome	IDH1 IDH2	7.99e-05	3	153	2	C0024454
Disease	Feeding difficulties	ZMIZ1 PPP2CA KAT8	1.05e-04	18	153	3	C0232466
Disease	Enchondromatosis	IDH1 IDH2	1.59e-04	4	153	2	C0014084
Disease	Combined D-2- and L-2-hydroxyglutaric aciduria	IDH2 SLC25A1	1.59e-04	4	153	2	C2746066
Disease	Hemangioma, Intramuscular	IDH1 IDH2	1.59e-04	4	153	2	C0205789
Disease	Histiocytoid hemangioma	IDH1 IDH2	1.59e-04	4	153	2	C0205788
Disease	Chorioangioma	IDH1 IDH2	1.59e-04	4	153	2	C0677608
Disease	Angioma	IDH1 IDH2	1.59e-04	4	153	2	C1959588
Disease	Hemangioma	IDH1 IDH2	1.59e-04	4	153	2	C0018916
Disease	Seizures, Focal	CYP11A1 MPDZ IDH2 SLC17A7 DYNC1H1	2.14e-04	104	153	5	C0751495
Disease	cortical surface area measurement	TNIK USP34 ANGPT1 NBEAL1 ACTN4 FRYL XKR6 PTCH1 PLXNB2 SNX13 CADPS NT5DC2 MACF1 FGFR2 PLS1 PDZRN3 PLXNA2 SOS2	2.21e-04	1345	153	18	EFO_0010736
Disease	Intrahepatic Cholangiocarcinoma	IDH1 IDH2 FGFR2	2.55e-04	24	153	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	IDH1 IDH2 FGFR2	2.55e-04	24	153	3	C3805278
Disease	Abnormality of head or neck	ZMIZ1 STAG2	2.64e-04	5	153	2	C4021817
Disease	Cholangiocarcinoma	IDH1 IDH2 FGFR2	3.26e-04	26	153	3	C0206698
Disease	magnesium measurement	DLK1 DLC1 DLEC1 FGFR2	3.90e-04	66	153	4	EFO_0004845
Disease	Biliary Tract Neoplasm	IDH1 IDH2	3.95e-04	6	153	2	C0005426
Disease	Childhood Oligodendroglioma	IDH1 IDH2	5.51e-04	7	153	2	C0280475
Disease	Adult Oligodendroglioma	IDH1 IDH2	5.51e-04	7	153	2	C0279070
Disease	Oligodendroblastoma	IDH1 IDH2	5.51e-04	7	153	2	C0344461
Disease	Mixed Oligodendroglioma-Astrocytoma	IDH1 IDH2	5.51e-04	7	153	2	C0280793
Disease	Mixed Oligodendroglioma-Ependymoma	IDH1 IDH2	5.51e-04	7	153	2	C0751395
Disease	Well Differentiated Oligodendroglioma	IDH1 IDH2	5.51e-04	7	153	2	C0751396
Disease	primary pulmonary hypertension (is_marker_for)	FGFR2 FBXO32	7.33e-04	8	153	2	DOID:14557 (is_marker_for)
Disease	oligodendroglioma	IDH1 IDH2	7.33e-04	8	153	2	C0028945
Disease	holoprosencephaly (is_implicated_in)	PTCH1 STAG2	7.33e-04	8	153	2	DOID:4621 (is_implicated_in)
Disease	Anaplastic Oligodendroglioma	IDH1 IDH2	7.33e-04	8	153	2	C0334590
Disease	Asthma	HLA-G PPP2CA ORMDL3 CTNNA3	8.09e-04	80	153	4	C0004096
Disease	age at onset, coronary stenosis	DLC1 DLEC1	9.39e-04	9	153	2	EFO_0004847, MONDO_0006715
Disease	QRS duration	USP34 OLFML2B ORMDL3 HMCN1 DLEC1 PLS1 PDZRN3	9.65e-04	298	153	7	EFO_0005055
Disease	acute myeloid leukemia (is_implicated_in)	IDH1 IDH2 CSF3R DLEC1	9.72e-04	84	153	4	DOID:9119 (is_implicated_in)
Disease	neurodegenerative disease (implicated_via_orthology)	UBR2 PTCH1 MYLIP SLC17A7 DYNC1H1	9.77e-04	145	153	5	DOID:1289 (implicated_via_orthology)
Disease	Malignant neoplasm of brain	IDH1 PTCH1 AMOT	1.01e-03	38	153	3	C0153633
Disease	nitric oxide exhalation measurement	ANGPT1 DLC1 DLEC1	1.01e-03	38	153	3	EFO_0005536
Disease	Brain Neoplasms	IDH1 PTCH1 AMOT	1.09e-03	39	153	3	C0006118
Disease	reticulocyte count	ATRN USP34 ARHGEF28 ANGPT1 HLA-G DLK1 ACTN1 PFKM PLXNB2 PELO NT5DC2 TMEM131L LRP5 PLS1	1.12e-03	1045	153	14	EFO_0007986
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-G XKR6 SNX13 MACF1 LRBA	1.14e-03	150	153	5	EFO_0004611, EFO_0020947
Disease	4-vinylphenol sulfate measurement	ANGPT1 SOS2	1.17e-03	10	153	2	EFO_0021149
Disease	Shortened QT interval	ABCC9 LRP5	1.42e-03	11	153	2	C0151879
Disease	Basal cell carcinoma	PTCH1 DDB2	1.42e-03	11	153	2	C0007117
Disease	neutropenia, response to gemcitabine	DLC1 DLEC1	1.42e-03	11	153	2	GO_0036272, MONDO_0001475
Disease	high grade glioma (implicated_via_orthology)	IDH1 IDH2 FGFR2	1.55e-03	44	153	3	DOID:3070 (implicated_via_orthology)
Disease	age-related hearing impairment	ARHGEF28 TMPRSS4 PTPN14 GPBP1L1 DLC1 FZD10 DLEC1	1.56e-03	324	153	7	EFO_0005782
Disease	epilepsy (implicated_via_orthology)	TNIK CHKB SCN9A DYNC1H1 KCNH5	1.64e-03	163	153	5	DOID:1826 (implicated_via_orthology)
Disease	Hematologic Neoplasms	IDH1 IDH2	1.70e-03	12	153	2	C0376545
Disease	Congenital neutropenia	JAGN1 CSF3R	1.70e-03	12	153	2	C0340970
Disease	Generalized seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0234533
Disease	Clonic Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0234535
Disease	Convulsive Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0751494
Disease	Seizures, Sensory	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0751496
Disease	Non-epileptic convulsion	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0751056
Disease	Atonic Absence Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0751123
Disease	Complex partial seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0149958
Disease	Single Seizure	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0751110
Disease	Nonepileptic Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C3495874
Disease	Visual seizure	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0270824
Disease	Epileptic drop attack	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0270846
Disease	Vertiginous seizure	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0422855
Disease	Gustatory seizure	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0422854
Disease	Seizures, Somatosensory	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0422850
Disease	Olfactory seizure	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0422853
Disease	Seizures, Auditory	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0422852
Disease	Generalized Absence Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C4505436
Disease	Jacksonian Seizure	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C0022333
Disease	Epileptic Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.92e-03	101	153	4	C4317109
Disease	Absence Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.99e-03	102	153	4	C4316903
Disease	Convulsions	CYP11A1 MPDZ IDH2 SLC17A7	1.99e-03	102	153	4	C4048158
Disease	Tonic Seizures	CYP11A1 MPDZ IDH2 SLC17A7	1.99e-03	102	153	4	C0270844
Disease	platelet component distribution width	ANGPT1 DLK1 ACTN1 ZMIZ1 CHKB NUP35 DLC1 TMEM131L MACF1 DLEC1 BRWD1	2.00e-03	755	153	11	EFO_0007984
Disease	Hereditary Motor and Sensory-Neuropathy Type II	MORC2 SCN9A	2.01e-03	13	153	2	C0270914
Disease	Skin Abnormalities	APAF1 FGFR2	2.01e-03	13	153	2	C0037268
Disease	aortic measurement	ANGPT1 ABCC9 ACTN4 MORC2 HMCN1 FBXO32	2.04e-03	251	153	6	EFO_0020865
Disease	Myoclonic Seizures	CYP11A1 MPDZ IDH2 SLC17A7	2.14e-03	104	153	4	C4317123
Disease	Tonic - clonic seizures	CYP11A1 MPDZ IDH2 SLC17A7	2.14e-03	104	153	4	C0494475
Disease	Drugs used in diabetes use measurement	ACTN1 ZMIZ1 PTCH1 PELO CTNNA3 MACF1	2.20e-03	255	153	6	EFO_0009924
Disease	neutrophil count	UBR2 GNPDA1 CEL COPA OLFML2B COX4I1 HLA-G DLK1 XKR6 ZMIZ1 SNX13 ZC3H7A PTPN14 CSF3R SLC25A1 LRBA	2.26e-03	1382	153	16	EFO_0004833
Disease	polycystic kidney disease (implicated_via_orthology)	ANKS6 IFT172	2.33e-03	14	153	2	DOID:0080322 (implicated_via_orthology)
Disease	Intellectual Disability	ZMIZ1 PPP2CA KAT8 MACF1 FGFR2 STAG2 PHIP DYNC1H1	2.39e-03	447	153	8	C3714756
Disease	fibrinogen measurement	CEL CHKB SNX13 PHIP	2.54e-03	109	153	4	EFO_0004623
Disease	glycerate measurement	RYR3 HMCN1	2.68e-03	15	153	2	EFO_0021029
Disease	Glioblastoma Multiforme	IDH1 IDH2 GUCY2F STAG2	2.71e-03	111	153	4	C1621958
Disease	Endometrial Neoplasms	CYP11A1 ABCC9 FGFR2	3.42e-03	58	153	3	C0014170
Disease	ankle injury	DLC1 IQCA1 DLEC1	3.59e-03	59	153	3	EFO_1002021
Disease	sleep duration, high density lipoprotein cholesterol measurement	DDB2 SNX13 ATP6V1H MACF1	3.69e-03	121	153	4	EFO_0004612, EFO_0005271
Disease	neuroimaging measurement	TNIK ANGPT1 NBEAL1 LRRC49 ACTN4 FRYL PTCH1 PLXNB2 CADPS MACF1 FGFR2 PDZRN3 PLXNA2	3.86e-03	1069	153	13	EFO_0004346
Disease	neuroimaging measurement, brain volume measurement	TNIK USP34 ACTN4 XKR6 FAM171B PTCH1	3.87e-03	286	153	6	EFO_0004346, EFO_0006930
Disease	inosine measurement	CTNNA3 KCNH5	4.31e-03	19	153	2	EFO_0010503
Disease	obsessive-compulsive disorder, autism spectrum disorder	DLC1 DLEC1	4.31e-03	19	153	2	EFO_0003756, EFO_0004242
Disease	Dyschondroplasias	IDH1 IDH2	4.31e-03	19	153	2	C0013366
Disease	DiGeorge syndrome (implicated_via_orthology)	DOCK1 SLC25A1	4.31e-03	19	153	2	DOID:11198 (implicated_via_orthology)
Disease	transitional cell carcinoma (is_marker_for)	ANGPT1 XPO5 FGFR2	4.32e-03	63	153	3	DOID:2671 (is_marker_for)
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	HLA-G XKR6 SNX13 MACF1	4.39e-03	127	153	4	EFO_0008595, EFO_0020947
Disease	optic disc size measurement	PTCH1 DLC1 CADPS MACF1 DLEC1	4.40e-03	205	153	5	EFO_0004832

Protein segments in the cluster

Peptide	Gene	Start	Entry
RIYIHMCLLWEQGQQ	NT5C1B	81	Q96P26
VKIWNSMTGELVHTY	APAF1	681	O14727
WEQKYLEENVMRHFA	AMOT	681	Q4VCS5
TNYTMEHIRVGWEQL	ACTN1	706	P12814
DYQRETWNLSNHEKM	AIPL1	161	Q9NZN9
NLKQAYWGHRELMLG	CHD5	636	Q8TDI0
IMYHINQNKWTLGVI	GPR34	111	Q9UPC5
NYTMEHIRVGWEQLL	ACTN4	726	O43707
RFMWIKHNNLYLVAT	AP1M1	56	Q9BXS5
VLNMQHWKSEDLAYV	C14orf28	226	Q4W4Y0
WLNYEAHLMKEGLTQ	ADGRG3	71	Q86Y34
NSEMWYKRHSIAIGE	DEPDC1B	151	Q8WUY9
LYEHWKTLMNRQDQE	ABCC9	906	O60706
NTLHEGWSQIMFRKQ	CAPN13	341	Q6MZZ7
LEHVMENYTQWLQKL	ANGPT1	86	Q15389
HWLFGTMERYLKQIQ	CHKB	186	Q9Y259
NYGLRDQHMAIAWVK	CEL	181	P19835
ETWVSNLRYNHMLRK	DLK1	331	P80370
YNKMWHQTQEALGAL	IQCA1	6	Q86XH1
NSAIIIQSWYRMHKE	ASPM	1466	Q8IZT6
QFKYLKNLLMIHGAW	ATP8A1	836	Q9Y2Q0
KNLLMIHGAWNYNRV	ATP8A1	841	Q9Y2Q0
RNAAVVMAVAQLYWH	AP3B1	311	O00203
LSNVDGTHWLEYIRM	MTMR1	401	Q13613
PIHWKLANVENYSRM	NBEAL1	1796	Q6ZS30
GYNIEQALGMLLWHK	RCOR2	101	Q8IZ40
LKEQYRESWMLHNSG	PDZRN3	711	Q9UPQ7
VGSPMWHVQQLEIKY	QRFPR	176	Q96P65
QQMAAKIVQATWRGH	IQCN	1136	Q9H0B3
EHAQGAVTKPRYMQW	ITPKC	526	Q96DU7
QLEKHTRYWPMIISQ	INTS13	451	Q9NVM9
HMKGSVAYVPQQAWI	ABCC3	686	O15438
AERSHLIVWQVMYGN	SPAG9	1306	O60271
YEIHTNSKEERNNWM	ARHGEF28	1166	Q8N1W1
WLHRYLENGKEMLQR	HLA-G	191	P17693
NMKHSGYLWAIGKNV	CADPS	521	Q9ULU8
GYKVRNQHWSLIMES	FGFR2	206	P21802
YLNIGRWRHKMVVLG	KLHL6	406	Q8WZ60
ALYKAIEEGVNHMWT	GNPDA1	211	P46926
RLLSHDQVAMPYQWE	JAGN1	61	Q8N5M9
QVTNYLGIEWMRRHL	GATM	271	P50440
VIKSHMTYWRLENIA	IL31RA	106	Q8NI17
EAEHRLLKAMGWQEY	GPBP1L1	386	Q9HC44
INMKSVVSWHYLINE	DST	971	Q03001
QSLNMVKYWKGQHVI	KAT8	401	Q9H7Z6
RASHKAVVNGNIMWV	ATRN	341	O75882
HLYWIDRQQQMIERV	LRP5	1166	O75197
WFYMQIAPIRNEHEK	KCNH5	106	Q8NCM2
LSLPHYNVIERVNWM	B3GALNT1	36	O75752
YEMIRVPVNWSHVNK	PLS1	431	Q14651
GDWKRLNTLMHYQVS	PLXNA2	1576	O75051
EGRWKRVNTLMHYNV	PLXNB2	1536	O15031
RSFMNNWEVYKLLAH	PFKM	376	P08237
QARNVQHYHMKTLGW	PGLYRP1	76	O75594
YLDNVNEHDWKMLRN	CES4A	401	Q5XG92
YSNWRLKVMEHNQGE	FRYL	1551	O94915
LKGNMLTRHRVWQYE	EVC2	326	Q86UK5
MVTIVHIYNRWKNSE	LRBA	301	P50851
IAQESWYKHTVLQNM	LRRC49	281	Q8IUZ0
LQIVSAMENYGIEWH	MYLIP	176	Q8WY64
VAMYEHKIFVQGIIW	GPI	491	P06744
LVSRAHQLVMEGYNW	PPP2CB	236	P62714
LVSRAHQLVMEGYNW	PPP2CA	236	P67775
MGYHILIWSQEEART	DDB2	411	Q92466
VEQSYQKVMALWHQL	MACF1	936	Q9UPN3
LHDLYWQAMKTLGVQ	MYBBP1A	1131	Q9BQG0
ITWYKNGRMITESTH	HMCN1	3091	Q96RW7
DMYTQAGRWEQAHKL	IFT172	946	Q9UG01
RAMGEHLAQYWKDIA	MORC2	441	Q9Y6X9
IYVLLKQWTHMNHQD	PIK3C2B	871	O00750
WDRGMQYSHSIITNL	GBA	396	P04062
MYKRTWENHIHVLTE	CTNNA3	481	Q9UI47
RLNMDYWKILAAQHK	FZD10	466	Q9ULW2
AQKIWYEHRLIDDMV	IDH1	241	O75874
NKIWYEHRLIDDMVA	IDH2	281	P48735
WLIHYMLGKVAEKQQ	CABIN1	1206	Q9Y6J0
IRDMWYNLGQHKIKF	DOCK1	1066	Q14185
TSLHNGVIQLWDYRM	COPA	26	P53621
WFNKGIEMHQRLSNI	EI24	221	O14681
LVTVMKYFQWAHAGV	GUCY2F	176	P51841
WTALMQATYHGNKEI	ANKS6	361	Q68DC2
QWHLYEMARNLKVQD	CYP11A1	336	P05108
KVWNSYTGQLLHNLM	BRWD1	451	Q9NSI6
KHLLLYQNMGIWVQA	CSF3R	191	Q99062
ALYKAIEEGVNHMWT	GNPDA2	211	Q8TDQ7
AWMNGLSVYQIKVHR	DYNC1H1	2951	Q14204
MLVERSTDYGHNWKV	LAMB4	141	A4D0S4
TQRKHNEVWMVDFYS	DNAJC10	571	Q8IXB1
WQHGTSLMNYLRMVE	GRIK4	341	Q16099
GNINMWVYRMETILH	FBXO32	191	Q969P5
IHKMVIWGANAYVTD	BPHL	156	Q86WA6
IGFTALVIMWQKHYV	COX4I1	111	P13073
HVELAFYWQIMKPNL	DLEC1	641	Q9Y238
ILLSWMNINYENTRH	CFAP47	1751	Q6ZTR5
MNINYENTRHVIWKN	CFAP47	1756	Q6ZTR5
RGMVKEHNNHLIWTY	FAM171B	306	Q6P995
RLLTHWEQMDYGVQF	ORMDL3	81	Q8N138
NTGNWMHIRYQSKLQ	NUP35	206	Q8NFH5
IQINMHIKDWLDRYE	TAS2R13	146	Q9NYV9
VHRRNLNSEEMWKTY	SNX13	596	Q9Y5W8
VVEVGRKHIIWMNHY	RNF133	176	Q8WVZ7
VQKLMVHNWEYLGKQ	ATP6V1H	456	Q9UI12
VLHLVYNQGMIWMGA	TMC3	561	Q7Z5M5
EKNNWMAALISLHYR	SOS2	531	Q07890
AVNMYILHSGNSLIW	TMEM131L	301	A2VDJ0
HTLATWYKSNMNGVR	OGA	326	O60502
MHIWENSVYDNVRSV	OVCH1	1081	Q7RTY7
IYRWNDMGNITHNKS	PTPN14	251	Q15678
SRKYMHWQEELIVGG	PTCH1	331	Q13635
AAWIPHVENRQMAYE	SCG2	481	P13521
KEGQSQHMTEVLYWI	SCN9A	1536	Q15858
WSRKTFVDNMKIYNH	ST8SIA1	201	Q92185
IVLSWIDQRLHIQMY	OR6T1	46	Q8NGN1
MWHTYNLVQVGDSLR	PELO	26	Q9BRX2
VGAMTKHKTREEWQY	SLC17A7	456	Q9P2U7
NVNTWQHRLELAMDY	POMK	171	Q9H5K3
AQSIHMYAARVQWGL	TMEM150C	186	B9EJG8
KQRYVAAWAMLHDVA	OLFML2B	591	Q68BL8
DGYVWQVTDMNRLHR	RO60	21	P10155
YHVKGMQRIVNQWSE	DLC1	911	Q96QB1
IMKHEVVIWLGDLNY	OCRL	411	Q01968
RITWDKSLQVYNMVH	STARD6	71	P59095
VYSMEHIRVGWEQLL	ACTN3	721	Q08043
ELLNYAWQHRESKME	RRP7BP	61	Q9NSQ0
TAYNKLHTWQSRRLM	GTF2H1	531	P32780
HLLQMGQVWRYIRTM	XKR6	246	Q5GH73
VAYIHSNQIMGWGEK	TNIK	1286	Q9UKE5
WQRIMGINYEIVVAH	MPDZ	541	O75970
IILEHLQWTMGYEVQ	NCAM2	651	O15394
MTLKVWNSYTGQLIH	PHIP	446	Q8WWQ0
YVGWTMHDKQGEVRL	STAG2	331	Q8N3U4
MKYHIWKLGVVFTDN	RYR3	4606	Q15413
RLAWVHATVYSQEKM	RNF123	821	Q5XPI4
TIMVLVNYIHFKAQW	SERPINA7	196	P05543
AVQMDVHDGRSWYIL	TTC5	171	Q8N0Z6
LMYQSDQWHVVGIVS	TMPRSS4	391	Q9NRS4
TYLHMRLSQKWQVIN	XPO5	921	Q9HAV4
TRMQGLEAHKYRNTW	SLC25A1	246	P53007
LKFRGEYNKHAQLWM	RXFP1	466	Q9HBX9
FQERQMLGTKHSYWI	TTLL2	196	Q9BWV7
DAIRDVHVKGLMYQW	NT5DC2	221	Q9H857
VHVKGLMYQWIEQDM	NT5DC2	226	Q9H857
LKIWHIDNQMDRYQG	ZNF630	116	Q2M218
YAHSLVELKVWIMQN	ZC3H7A	651	Q8IWR0
QLMIYVWAMEQKNRH	TRMT9B	136	Q9P272
MVKGSVENYRLIHNW	USP34	1851	Q70CQ2
HLTQAVESYKQRMDW	VWA3B	111	Q502W6
MVHQVLYRALVSTKW	TST	1	Q16762
VHWYRQNLRQEMKLL	TRBV17	51	A0A087X0K7
EQFKMSERLHGNWIR	PIGG	376	Q5H8A4
HNGYAWSESMLQRVL	UBR2	911	Q8IWV8
VMEGYKWHFNETVLT	PPP4C	241	P60510
QLWTHYDVMDNLLIQ	TYW5	156	A2RUC4
ENDQSTHKWMVYVRG	YEATS2	226	Q9ULM3
DQYMWGILNAIQHSE	ZMIZ1	796	Q9ULJ6
PVNWHKNYAIACERM	TMEM260	636	Q9NX78
GHLNWGQKDLYRDVM	ZNF789	26	Q5FWF6
HNDWVMKIRYISALN	WDR64	276	B1ANS9
EDWQKELYKHVMRGN	ZNF783	161	Q6ZMS7
KVWLLQQYSGMTHED	ZC3H7B	641	Q9UGR2
IVQESKKYWQQMEAH	ZC3H7B	656	Q9UGR2
AQLVQKAHELMWYVL	NDN	96	Q99608